Test bank for Tietz Fundamentals of Clinical Chemistr
and Molecular Diagnostic
8th Edition by Nader Rifai, Ph
Chapters 1 - 4
,TietzBFundamentalsBofBClinicalBChemistryBandBMolecularBDiagnosticsB8thB EditionBTestBBank
TableBofBcontents:
I.BPrinciplesBOfBLaboratoryBMedicine
ChapterB1.BClinicalBChemistry,BMolecularBDiagnostics,BandBLaboratoryBMedicine
ChapterB2.BSelectionBandBAnalyticalBEvaluationBofBMethodsB—BWithBStatisticalBTechniques
ChapterB3.BClinicalBEvaluationBofBMethods
ChapterB4.BEvidence-BasedBLaboratoryBMedicine
ChapterB5.BEstablishmentBandBUseBofBReferenceBValues
ChapterB6.BSpecimenBCollection,BProcessing,BandBOtherBPreanalyticalBVariables
ChapterB7.BQualityBManagement
II.BAnalyticalBTechniquesBAndBInstrumentation
ChapterB8.BPrinciplesBofBBasicBTechniquesBandBLaboratoryBSafety
ChapterB9.BOpticalBTechniques
ChapterB10.BElectrochemistryBandBChemicalBSensors
ChapterB11.BElectrophoresis
ChapterB12.BChromatography
ChapterB13.BMassBSpectrometry
ChapterB14.BEnzymeBandBRateBAnalyses
ChapterB15.BImmunochemicalBTechniques
ChapterB16BAutomation
ChapterB17.BPoint-of-CareBInstrumentation
III.B Analytes
ChapterB18.BAminoBAcids,BPeptides,BandBProteins
ChapterB19.BSerumBEnzymes
ChapterB20.BTumorBMarkersBandBCancerBGenes
ChapterB21.BKidneyBFunctionBTestsB—BCreatinine,BGFR,BUrea,BandBUricBAcid
ChapterB22.BCarbohydrates
ChapterB23.BLipids,BLipoproteins,BApolipoproteins,BandBOtherBCardiacBRiskBFactors
ChapterB24.BElectrolytesBandBBloodBGases
ChapterB25.BHormones
ChapterB26.B CatecholaminesBandBSerotonin
ChapterB27.B Vitamins,BTraceBElements,BNutritionalBAssessment
ChapterB28.BHemoglobin,BIron,BandBBilirubin
ChapterB29.BPorphyrinsBandBPorphyrias
ChapterB30.BTherapeuticBDrugsBandBTheirBManagement
ChapterB31.BClinicalBToxicology
ChapterB32.B ToxicBMetals
IV.B Pathophysiology
ChapterB33.BDiabetes
,ChapterB34.B CardiovascularBDisease
ChapterB35.BKidneyBDisease
ChapterB36.B PhysiologyBandBDisordersBofBWater,BElectrolyte,BandBAcid-BaseBMetabolism
ChapterB37.BBLiverBDisease
ChapterB38.B GastrointestinalBandBPancreaticBDiseases
ChapterB39.BBDisordersBofBBoneBandBMineralBMetabolism
ChapterB40.BBDisordersBofBtheBPituitaryBGland
ChapterB41.B DisordersBofBtheBAdrenalBCortex
ChapterB42.B ThyroidBDisorders
ChapterB43.B Reproduction-RelatedBDisorders
ChapterB44.BBPregnancyBandBPrenatalBTesting
ChapterB45.B NewbornBScreeningBandBInbornBErrorsBofBMetabolism
ChapterB46.BPharmacogenetics
V.B MolecularBDiagnostics
ChapterB47.BPrinciplesBofBMolecularBBiology
ChapterB48.BNucleicBAcidBTechniquesBandBApplications
ChapterB49.BGenomesBandBNucleicBAcidBAlterations
, ChapterB01:BClinicalBChemistry,BMolecularBDiagnostics,BandBLaboratoryBMedicineBTestBBan
k
MULTIPLEBCHOICE
1. AnBindividualBworkingBinBaBclinicalBchemistryBlaboratoryBisBmarriedBtoBaBsalesBrepresentativeB
whoBworksBforBaBcompanyBthatBsellsBchemistryBlaboratoryBsupplies.BWhenBtheBlaboratoryBma
nagerBrequestsBaBlistBofBneededBsupplies,BcostBofBsupplies,BandBvendors,BthisBindividualBonlyBr
ecommendsBtheBspouse’sBcompanyBasBtheBvendor.BThisBisBconsideredBtoBbeBa(n):
a. accountingBissue.
b. possibleBconflictBofBinterest.
c. maintenanceBofBconfidentialityBissue.
d. problemBwithBresourceBallocation.
ANS:B B
ConcernBhasBbeenBraisedBoverBtheBinterrelationshipsBbetweenBpractitionersBinBtheBmedicalBfi
eldBandBcommercialBsuppliersBofBdrugs,Bdevices,Bequipment,Betc.,BtoBtheBmedicalBprofession.
Similarly,BrelationshipsBhaveBbeenBscrutinizedBbetweenBclinicalBlaboratoriansBandBmanufactur
ersBandBprovidersBofBdiagnosticBequipmentBandBsupplies.BTheseBconcernsBledBtheBNationalBInst
itutesBofBHealthB(NIH)BinB1995BtoBrequireBofficialBinstitutionalBreviewBofBfinancialBdisclosureBbyB
researchersBandBmanagementBofBsituationsBinBwhichBdisclosureBindicatesBpotentialBconflictsBofB
interest.
DIF: 1 REF:BBBPageB4-5 OBJ:B 6B|B7
2. ABpatientBvisitsBherBphysicianBstatingBthatBherBprescribedBpainkillerBisBnotBworkingBtoBreduc
eBtheBpainBfollowingBherBrecentBsurgery.BABfriendBofBtheBpatientBclaimsBthatBtheBsameBpainki
llerB“workedBwonders”BtoBreduceBherBpainBafterBtheBsameBsurgery.BTheBphysicianBstatesBtha
tBtheBdifferenceBinBtheBeffectBofBtheBdrugBmightBbeBcausedBby
,BwhichBisBstudiedBinBpharmacogenetics.
a. epidemiology
b. anBinheritedBdisease
c. aBconflictBofBinterest
d. aBgeneticBvariationBinBdrug-metabolizingBenzymes
ANS:B D
PharmacogeneticsBisBtheBstudyBofBtheBgeneticBvariationBofBdrugBmetabolismBbetwe
enBindividuals.
DIF: 1 REF:BBBPageB3 OBJ:B 1
3. JohnBworksBinBaBmolecularBdiagnosticsBlaboratoryBandBreceivesBaBbloodBsampleBthatBhasBth
eBnameBofBaBcloseBfriendBprintedBonBtheBbar-
codedBlabel.BTheBgeneticBtestBthatBisBorderedBonBtheBfriend’sBsampleBwouldBprovideBdiagnos
ticBinformationBaboutBaBdisorderBthatBhasBaBpoorBprognosis,BandBtheBtestBisBusuallyBperform
edBbyBJohn.BHeBasksBaBfellowBemployeeBtoBanalyzeBtheBsampleBforBhimBandBnotBdivulgeBtheBr
esults.BThisBethicalBissueBconcerns:
a. confidentialityBofBpatientBgeneticBandBmedicalBinformation.
b. aBconflictBofBinterest.
c. resourceBallocation.
d. diagnosticBaccuracy.
